Quantitative real-time polymerase chain reaction (Q-PCR) can be a valuable tool in the operating room to determine whether head and neck cancer patients should go on to elective neck dissection, researchers said here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.
Neurotrophic factors can be introduced using stem cells and, along with the plant alkaloid vincristine, can be used to selectively reinnervate the larynx in rat models, a researcher from Indiana University said here on April 29 at the Annual Meeting of the Triological Society, held as part of the Combined Otolaryngology Spring Meetings.
What are important parameters that should be considered in the treatment decisions for vestibular schwannomas? Background: The advent of stereotactic radiosurgery and its widespread use during the past decade have led […]
What are the patient variables associated with swallowing dysfunction in head and neck cancer (HNCa) patients prior to intervention? Background: Recent studies have shown that pretreatment deficits are common in HNCa […]
Is there evidence of extraesophageal reflux (EER) in idiopathic subglottic stenosis (iSGS)? Background: Although a subset is related to identifiable trauma, many stenoses in the upper airway are deemed idiopathic. Theories […]
Can drug-induced sleep endoscopy (DISE) help determine the mechanisms for lack of response to surgery for obstructive sleep apnea (OSA)? Background: The most common OSA surgical treatment in the U.S. is […]
Surgically releasing specific “trigger sites” may provide long-term relief for some sufferers of chronic migraine. According to a recent study published in Plastic and Reconstructive Surgery, 88 percent of patients who underwent surgical deactivation of targeted trigger sites reported at least a 50 percent reduction in the frequency, severity and duration of their migraine headaches five years later.
When performing certain procedures, many otolaryngologists use succinylcholine, a neuromuscular blocking agent, to help them monitor the facial nerve.
Regarding the article, “Otolaryngologist Pioneers New Practice Model: Dr. Russell heralds hospitalist role as others ponder the concept’s staying power”…
For decades, otolaryngologists have been frustrated by the refusal of some patients with hearing loss to use hearing aids. Statistics on noncompliance vary, but there is general agreement that only about 20 percent to 25 percent of Americans with treatable hearing loss use hearing aids. The problem seems to be more acute for people with mild hearing loss: A consumer survey conducted by the nonprofit Better Hearing Institute in 2009 found that fewer than 10 percent of people with mild hearing loss use amplification and that even among people with moderate-to-severe hearing loss, only four in 10 use amplification.